(b)(4).Title randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma.Source br j surg, volume 104, 2017(1775-1784) article number: 13 date of online publication: 1 nov 2017.If information is provided in the future, a supplemental report will be issued.
|
According to the literature study performed july 2002 to june 2007, in a randomized trial aimed to test the hypothesis that radiofrequency ablation (rfa) is superior to hepatic resection in terms of lower tumour recurrence rate and better long-term survival.Patients with early-stage hepatocellular carcinoma hcc (solitary tumour no larger than 5 cm; or no more than 3 tumours, each 3 cm or smaller) were randomized into hepatic resection and rfa groups.Rfa was performed using an internally cooled electrode.Out of 109 patients in the rfa group, 1 had pneumonia, 2 with peptic ulcer, 3 with unspecified post-operative complications and another had its wound infected.
|